Athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. This pipeline includes both stem cell therapy and pharmaceuticals.
Looking for a particular Athersys employee's phone or email?
The Athersys annual revenue was $6 million in 2026.
Jeff Randall is the Board Member of Athersys.
23 people are employed at Athersys.
Athersys is based in Cleveland, Ohio.
The NAICS codes for Athersys are [32, 325, 32541, 3254].
The SIC codes for Athersys are [283, 28, 87, 873].